Oliver Luxxe Assets’s Regeneron Pharmaceuticals REGN Stock Holding History

Oliver Luxxe Assets’s Portfolio REGN Stock Details REGN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.59M	Buy
2022 Q1	–	Sell
2021 Q4	$4.63M	Buy
2021 Q3	$4.34M	Buy